1399. Efficacy of Daptomycin Combination with β-Lactams for Daptomycin-resistant Enterococcus faecium Harboring LiaSR Substitutions

BACKGROUND: Daptomycin (DAP) is one of the mainstay treatments for Enterococcus faecium infections. However, development of resistance threatens its continued viability as a treatment option. Although the mechanisms of DAP resistance in enterococci are not fully comprehended, they are associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kebriaei, Razieh, Rice, Seth, Singh, Kavindra, Stamper, Kyle, Dinh, An, Rios, Rafael, Diaz, Lorena, Murray, Barbara, Munita, Jose M, Tran, Truc T, Arias, Cesar, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252901/
http://dx.doi.org/10.1093/ofid/ofy210.1230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252901/
http://dx.doi.org/10.1093/ofid/ofy210.1230

Ejemplares similares